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Abstract 
Introduction: 4D Ultrasound technology merging the Power Doppler option called High-Definition Flow (HDF) with Spatio-Temporal 
Image Correlation (STIC) is used in gynaecology and obstetrics. It seems to be a promising tool in assessing tissue vascularisation. The 
aim of the paper was to assess whether HDF STIC technique could be a useful tool for the evaluation of gastro-entero-pancreatic neuro-
endocrine neoplasm (GEP-NEN) advancement.
Material and methods: Forty-eight patients [mean age 57.7 ± 10.3 years; male 40.9% (n = 18)] diagnosed with metastatic GEP-NENs 
were included in the analysis. All subjects were enrolled in the Department of Endocrinology and Neuroendocrine Tumours, Medical 
University of Silesia, Katowice. We analysed liver metastases. Patients with G3 grading or faintly vascularised lesions were excluded. 
HDF STIC volumes were acquired during USG examination. 4D indices [volumetric pulsatility index (vPI) and volumetric systolic/diastolic 
index (vS/D)] were calculated using dedicated software.
Results: There were no correlations between vS/D and Ki-67 [p = 0.67; r = –0.19; (–0.28–0.19)], CgA [p = 0.47; r = –0.11; (–0.38–0,19)], 
5-HIAA [p = 0.52; r = –0.09 (–0.37–0.2)], serotonin [p = 0.83; r = –0.03 (–0.32–0.26)], and VCAM-1 (p = 0.62; r = 0.09 (–03–0.47)]. The were 
no correlations between vPI and Ki-67 [p = 0.29; r = –0.16 (–0.45–0.14)], CgA (p = 0.46; r = –0.11 (–0.39–0.19)], 5-HIAA [p = 0.52; r = –0.09 
(–0.37–0.2)], serotonin [p = 0.82; r = –0.03 (–0.32–0.26)], and VCAM-1 (p = 0.62; r = –0.09 (–03–0.47)]. There was no significant difference 
between carcinoid versus non-carcinoid patients if compared by vS/D and vPI (p = 0.62, p = 0.61, respectively).
Conclusions: HDF STIC seems not to be an efficient marker to assess advancement of NENs, due to lack of correlation with widely used 
and approved markers of progression. (Endokrynol Pol 2019; 70 (3): 219–223)
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Introduction
Neuroendocrine neoplasms (NENs) are a heterogeneous 
group of relatively rare neoplasms developing from dif-
fuse endocrine system cells. About 70% of all NENs are 
gastro-entero-pancreatic neuroendocrine neoplasms 
(GEP-NENs), which constitute approximately 2% of all 
gastrointestinal tract neoplasms. NENs could produce 
hormones, peptides, and biogenic amines. Predomi-
nantly the amount of those substances is insufficient to 
present clinical symptoms (non-functional NENs) [1]. 
Over 50% of GEP-NENs are metastatic at diagnosis [1–3]. 
65–95% of those tumours show hepatic metastasis [3]. 
Transabdominal ultrasonography, due to its wide 
availability and low cost, is generally the first imaging 
technique performed in diagnosing abdominal disor-
ders. The sensitivity of the exam is determined by the 
lesion location, anatomical and technical conditions, as 
well as the physician’s experience [1].
Characteristic ultrasonography features of neuroen-
docrine liver metastases are mixed hyper/hypoechoic 
pattern with central cystic areas and hyper-vasculari-
sation in colour/power Doppler imaging [1, 3].
High-definition flow (HDF) is a recent advance 
in Doppler technology. This technique is more sensi-
tive to slow-flow small vessels than other Doppler 
techniques [4–5]. New software allows the calcula-
tion of three-dimensional (3D) indices using HDF 
imaging [6]. Spatiotemporal image correlation (STIC) 
enables the acquisition of gated single cardiac cycle in 
a four-dimentional (4D) technique, obtaining data in 
space and time [4, 7]. This technique is routinely used 
in obstetrics and gynaecology diagnostics.  Diagnosis 
of NENs is expensive and time-consuming; therefore, 
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tion index, determined by immunohistochemical analysis. NEN G1 
was defined as Ki-67 < 3%, G2 3–20%, and G3 > 20%.
Study definitions
Using the obtained vascularisation index (VI) two 4D ratios were 
calculated: the volumetric pulsatility index: vPI = (systolic VI 
– diastolic VI) / mean VI and the volumetric systolic/diastolic index: 
vS/D = systolic VI / diastolic VI.
Safety and ethics
This prospective nonrandomised observational study was 
conducted with standard ethical guidelines. The agreement of 
the local Bioethics Committee was obtained before any study 
procedure. 
Statistical analysis
Continuous variables are presented as mean±SD or median (IRQ). 
Data were compared using Student’s t-test for parametric and U-
Mann Whitney test for non-parametric continuous variables. For 
correlation assessment Pearson test was used for parametric and 
Spearman test for nonparametric variables. Categorical variables 
are reported as frequencies (percentage). All reported P-values are 
two-tailed, and p < 0.05 was considered significant. GraphPad 6 
Prism was used for statistical analysis.
Results
Sixty-two patients were enrolled in the study. After 
histopathological analysis seven subjects were excluded 
due to G3 grading. The remaining patients had USG 
with DUS performed, and the subsequent seven pa-
tients were excluded from analysis due to faintly vascu-
larised metastases. Forty-eight patients were included 
to STIC-HDF analysis.  
Mean patient age was 57.7 ± 10.3 years, and 40.9% 
(n = 18) were male. The mean body mass index was 
24.1 ± 4.7. Patients’ demographic data are shown in 
Table  I. In USG assessment, the mean vertical and 
horizontal diameters of metastases chosen for STIC 
evaluation were 36.9 ± 19.8 mm and 36.1 ± 21.5 mm, 
respectively.
The pancreas was the most common primary tu-
mour site (PTS) — 39.6% (n = 19), and second most 
common PTS was the ileocecal valve and small intestine. 
in this study, we would like to assess whether STIC 
technique could be a useful tool for evaluation of NEN 
advancement.
Material and methods
Subject
Sixty-two patients were enrolled in this prospective study. All 
subjects enrolled in the Department of Endocrinology and Neu-
roendocrine Tumours, Medical University of Silesia, Katowice 
were diagnosed with GEP-NEN or NEN of unknown primary 
site with liver metastases. In all patients, liver metastases were 
confirmed in non-invasive imaging tests like ultrasonography, 
magnetic resonance, computed tomography, and positron emission 
tomography. Moreover, in all cases NEN diagnosis was confirmed 
in histopathological examination performed by an experienced 
pathomorphologist. Only subjects with NEN grading G1 or G2 were 
included. Patients with faintly vascularised liver metastases and 
those diagnosed with NEN G3 were excluded from analysis. What 
is more, none of the patients included in the study was diagnosed 
with any other type of cancer.
Procedural characteristic
Ultrasonography (US) and Doppler ultrasonography imaging 
(DUS) of the liver were performed in all patients included in this 
study. Ultrasonography was performed by single physician with 
10 years’ experience in abdominal US using the Voluson E8 Expert 
System (GE Healthcare) equipped with a 3D/4D Matrix Convex 
Probe (GE RM6C). If many metastases were found in the liver, the 
most vascularised one was chosen for analysis.
The sonographic protocol and volume analysis have been reported 
elsewhere [5–8].
 
The two-dimensional HDF gate was activated and 
superimposed over the dominant metastases to assess the highest 
vascularisation area. The long axis of the transducer (i.e. the main 
y-axis on the sonographic screen) was then directed to this point 
while collecting the sweep. Subsequently, STIC was activated, and 
a 4D STIC-HDF volume was acquired from the patient (who was 
asked to remain as still as possible) and then saved for further evalu-
ation. Volume acquisition was repeated when flash-type artefacts 
appeared due to respiratory movements. 
The 3D volume size of the region of interest was set up in the system 
as constant to cover identical size volumes for all the cases. The HDF 
Doppler settings were set as follows: HDF window angle, 70°; zoom, 
1.4; depth of the HDF window, 40 mm; pulse repetition frequency, 
0.3 kHz; gain, 0.2; frequency, mid; HDF quality, normal; wall mo-
tion filter, low 1; smooth, 3/5; ensemble, 10; flow resolution, mid 2; 
line density, 9; balance, greater than 180; and HD map, 1. The HDF 
refreshing frequency resulting from such settings was 15 Hz. The 
STIC sweep angle was 40°, and the acquisition time was 15 seconds. 
4D STIC-HDF analyses were performed using dedicated software 
— 4DView GE Healthcare Version 10.2. First a chain of 3D HDF 
volumes forming the STIC loop was activated to choose the mo-
ment of highest and lowest vascularisation of the liver lesion. The 
point of highest vascularisation was brought into the centre of the 
screen (on the y-axis), and each volume of the chain was saved as 
3D record. A sphere volume of 1 cm3 was set by the operator. After 
accepting the volume size, HDF histograms were calculated auto-
matically. Two 3D volumes with VI (vascularisation index) values 
were picked — the highest for systole and the lowest for diastole. 
Values were saved for further analysis.
All patients underwent a complete biochemical evaluation, includ-
ing serum levels of chromogranin A (CgA), serotonin, and vascular 
cell adhesion molecule-1 (VCAM-1), as well as carcinoid syndrome 
screening including daily urinary excretion of 5-hydroxyindoleace-
tic acid (5-HIAA). Blood and urine specimens were collected during 
hospitalisations when metastases in the liver were discovered. 
Assessment of histological malignancy was based on Ki-67 prolifera-
Table I. Patients’ demographic data
Demographic characteristic % (n)
Diabetes 29.2% (14)
Hypertension 54.2% (26)
Dyslipidaemia 39.6% (19)
Any thyroid dysfunction 79.2% (38)
Other endocrinology disease 29.2%(14)
Coronary Artery Disease (CAD) 6.3% (3)
Anaemia 43.8% (21)
Renal impairment 25% (12)
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The detailed PTS are shown in Table II. The mean vS/D 
was 1.25 ± 2.71, whereas the mean vPI was 0.28 ± 0.28. 
There were no correlations between vS/D and 
Ki-67 [p = 0.67; r = –0.19; (–0.28–0.19)], CgA [p = 0.47; 
r = –0.11; (–0.38–0,19)], 5-HIAA [p = 0.52; r = –0.09 
(–0.37–0.2)], serotonin [p = 0.83; r = –0.03 (–0.32–0.26)], 
and VCAM-1 [p = 0.62; r = 0.09 (–03– 0.47)] (Fig. 1). The 
were no correlations between vPI and Ki-67 [p = 0.29; 
r = –0.16 (–0.45– 0.14)], CgA [p = 0.46; r =–0.11 
(–0.39–0.19)], 5-HIAA [p = 0.52, r = –0.09 (–0.37–0.2)], 
serotonin [p = 0.82; r =–0.03 (–0.32–0.26)], and VCAM-1 
[p = 0.62; r = –0.09 (–03– 0.47)] (Fig. 2). Moreover, there 
were no significant differences between carcinoid ver-
sus non-carcinoid patients if compared by vS/D and vPI 
p = 0.62 and p = 0.61, respectively (Fig. 3).
Discussion
This current prospective study reports the assessment 
of STIC technique for evaluation of neuroendocrine 
liver metastases. To the best of our knowledge, the 
present study, for the first time, describes an attempt 
to use STIC in the evaluation of NEN advancement. 
In this single-arm, prospective study the STIC did not 
show any correlation with Ki-67 and other biomark-
ers of NENs, like chromogranin A, 5-HIAA, serotonin, 
and VCAM-1. Moreover, there were no differences in 
vS/D and vPI between patients with functional and 
non-functional NENs. It is worth noting that 12.7% (7) 
of patients had metastases that could not be assessed 
in STIC due to faint vascularity.
STIC technology is widely used in gynaecology and 
obstetrics. It is an efficient method in 4D foetal echocar-
diography used for prenatal screening of heart defects 
[9]. The 3D sampling technology used in our study 
was previously described as a promising method for 
evaluation of ovarian tumours. In a study in which 27 
Table II. Primary tumour site location
Primary tumour site % (n)
Pancreas 39.6% (19)
Ileocecal valve 12.5% (6)
Small intestine 12.5% (6)
Rectum 2.1 % (1)
Stomach 4.2 % (2)
Ampulla of Vater 2.1 % (1)
Unknown 27.1% (13)
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Figure 2. Graph of correlation between volumetric pulsatility index (vPI) vs. Ki-67 and other biochemical markers
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Figure 1. Graph of correlation between volumetric systolic/diastolic index (vS/D) vs. Ki-67 and other biochemical markers
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cases of ovarian tumours were analysed, and 53 healthy 
women formed the control group, a virtual spherical 
tissue sample of 1 cm2 was taken from the place of 
highest vessel density contained within the contours 
of the gland. Spherical sampling with 3D ultrasound 
power Doppler angiography achieved a higher degree 
of discrimination between the groups compared to the 
whole solid-part approach. The authors presumed that 
this is a sensitive approach to differentiate between 
tumour and healthy tissue [10]. 
Recently Polanski et al. tried to assess whether STIC 
vascularity indices correlate with assisted reproduc-
tive treatment outcomes. The authors concluded that 
this method is not a useful tool to predict outcomes 
of the mentioned treatment; however, it seemed to be 
more accurate in predicting first-trimester pregnancy 
loss [11].
Kim et al. compared HDF Doppler technique with 
colour Doppler ultrasonography and power Doppler 
ultrasonography for assessment of hepatic vasculature 
in native and transplanted liver. Their study revealed 
that HDF technique provides better resolution to de-
pict hepatic vessels and improve sensitivity to small 
vessels [4].
Kudla and Alcazar proved that STIC combined with 
HDF is a useful tool for assessing ovarian vascularisa-
tion [5–8]. The first study affirmed that 3D vascular in-
dices are higher when calculated using HFD than when 
using conventional power Doppler (PD). The authors 
concluded that HDF technique is more sensitive than 
PD in obtaining Doppler signals [7]. The next paper 
showed that the STIC-HDF method allows evaluation 
of 3D vascular indices in the cardiac cycle, and the 
vascularisation index (VI) depends on the moment of 
cardiac cycle whereas the flow index (FI) seemed to be 
independent of the cardiac cycle [5]. Another analysis 
pointed out that assessment of ovarian vascularisation 
using STIC-HDF spherical sampling is reliable. The 
authors introduced also new 4D vascular indices [6]. 
The recent study showed that calculating the mean VI 
using entire STIC sequence is as valuable as calculat-
ing VI choosing the highest and lowest colour signals 
determined by the operator [8].
Data about use of the STIC-HDF method are lim-
ited. In the available source literature this method 
seems to be a promising tool for assessing tissue vas-
cularisation. Diagnosing NENs requires expensive and 
advanced imaging methods. Therefore, in our study we 
tried to find an accessible and cost-effective method for 
neuroendocrine liver metastases assessment. However, 
according to our results, this method seems to have 
limited usage for evaluation of disease advancement.
Study limitations
The main limitation of this study is a lack of comparison 
STIC in patients with different progression free-surviv-
al. Moreover, the choice of most vascularised metastases 
was done subjectively by an ultrasonographer.
One of the basic limitations of using this method in the 
case of metastasis of neuroendocrine tumors in the liver 
turned out to be Power Doppler sensitivity to tissue 
movements. Our results of the Power Doppler STIC 
indices in the liver in comparison to previous ovarian 
observations are burdened with low vascularisation of 
the neuroendocrine metastatic tumors and an error due 
to artifacts originating from the heart and large vessel 
movements due to their close location.
Conclusions
In this hypothesis-generating prospective study, STIC 
was not an efficient marker for assessment of advance-
ment of NENs, due to lack of correlation with widely 
used and approved markers of progression.
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Figure 3. Graph of correlation between volumetric systolic/diastolic index (vS/D) vs. functional and non-functional neuroendocrine 
neoplasms (NENs) and volumetric pulsatility index (vPI) vs. functional and non-functional NENs
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